KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolent Health (EVH) Net Cash Flow (2016 - 2025)

Evolent Health (EVH) has 11 years of Net Cash Flow data on record, last reported at $37.9 million in Q4 2025.

  • For Q4 2025, Net Cash Flow fell 25.33% year-over-year to $37.9 million; the TTM value through Dec 2025 reached $2.7 million, up 106.0%, while the annual FY2025 figure was $2.7 million, 106.0% up from the prior year.
  • Net Cash Flow reached $37.9 million in Q4 2025 per EVH's latest filing, up from -$34.8 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $99.3 million in Q1 2025 and bottomed at -$99.8 million in Q2 2025.
  • Average Net Cash Flow over 5 years is -$9.0 million, with a median of $4.5 million recorded in 2023.
  • Peak YoY movement for Net Cash Flow: plummeted 4814.19% in 2021, then surged 5063.93% in 2024.
  • A 5-year view of Net Cash Flow shows it stood at $73.2 million in 2021, then tumbled by 72.15% to $20.4 million in 2022, then crashed by 105.02% to -$1.0 million in 2023, then soared by 5063.93% to $50.8 million in 2024, then fell by 25.33% to $37.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Net Cash Flow were $37.9 million in Q4 2025, -$34.8 million in Q3 2025, and -$99.8 million in Q2 2025.